OncoMatch

OncoMatch/Clinical Trials/NCT04892173

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Is NCT04892173 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies multiple treatments including JNJ-90301900 (NBTXR3) and Cetuximab for locally advanced head and neck squamous cell carcinoma.

Phase 3RecruitingJohnson & Johnson Enterprise Innovation Inc.NCT04892173Data as of May 2026

Treatment: JNJ-90301900 (NBTXR3) · CetuximabThis is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).

Check if I qualify

Extracted eligibility criteria

Cancer type

Head and Neck Squamous Cell Carcinoma

Disease stage

Required: Stage T3-4 NX, T2 N2-3

Excluded: Stage T1-2 N0, T2 N1

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Prior therapy

Cannot have received: surgery, radiation therapy, and/or chemotherapy for head & neck cancer

Loco-regionally recurrent head & neck cancer that has been previously treated with surgery, radiation therapy, and/or chemotherapy

Lab requirements

Kidney function

Estimated creatinine clearance >= 30 and < 50 mL/min (per Cockcroft-Gault equation)

Cardiac function

New York Heart Association Class 3

Estimated creatinine clearance >= 30 and < 50 milliliters/minute (mL/min) (per Cockcroft-Gault equation), Grade >= 2 hearing loss or tinnitus, Grade >= 2 peripheral neuropathy, Eastern Cooperative Oncology Group (ECOG) Performance Status 2 or New York Heart Association Class 3

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • University of Alabama at Birmingham · Birmingham, Alabama
  • City of Hope · Duarte, California
  • University of California at San Diego Moores Cancer Center · La Jolla, California
  • Memorial Radiation Oncology Medical Group Laguna Hills · Laguna Hills, California
  • UCLA Hematology Oncology · Los Angeles, California

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify